Sponsor: Alliance for Clinical Trials in Oncology
Sponsor Study ID: A032303
Study Title: GAIN-BCG: Gemcitabine Alternating With Intravesical BCG Randomized Against BCG Alone For Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer
CTO #: 104249
NCT Number: NCT07000084
Phase: III
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Bladder
Study Objectives: To compare high-grade recurrence-free-survival between treated with GemBCG compared to those treated with BCG alone.